Jurandyr Moreira de Andrade

ORCID: 0000-0003-3619-0582
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Ovarian cancer diagnosis and treatment
  • Women's cancer prevention and management
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Endometrial and Cervical Cancer Treatments
  • Cancer Risks and Factors
  • Cervical Cancer and HPV Research
  • Gestational Trophoblastic Disease Studies
  • Cancer Treatment and Pharmacology
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Uterine Myomas and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related Molecular Pathways
  • Prenatal Screening and Diagnostics
  • Reproductive System and Pregnancy
  • Immune cells in cancer
  • Monoclonal and Polyclonal Antibodies Research
  • Psoriasis: Treatment and Pathogenesis
  • Cytokine Signaling Pathways and Interactions
  • Immune Cell Function and Interaction
  • Infrared Thermography in Medicine

Universidade Brasil
1997-2024

Universidade de Ribeirão Preto
2007-2024

Universidade de São Paulo
2015-2024

Universidade Católica de Brasília
2024

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2008-2023

Hospital Universitário da Universidade de São Paulo
2021

IQVIA (France)
2021

Clinics Hospital of Ribeirão Preto
2007-2020

Keck Hospital of USC
2017

Centro Paulista de Investigação Clinica
2012

Sandra M. Swain David Miles Sung‐Bae Kim Young‐Hyuck Im Seock‐Ah Im and 95 more Semiglazov Vf Eva Ciruelos Andreas Schneeweiß Sherene Loi Estefanía Monturus Emma Clark Adam Knott Eleonora Restuccia Mark Benyunes Javier Cortés Richy Agajanian Rizvana Ahmad Bahriye Aktas Victor Hugo Medeiros Alencar Dino Amadori Jurandyr Moreira de Andrade Fábio Franke Catia Angiolini Kenjiro Aogi Jess F. Armor Wichit Arpornwirat L. Assersohn William Audeh Walter E. Aulitzky Sérgio Jobim Azevedo Maria Alejandra Bartoli Norberto Batista López María Inés Bianconi Laura Biganzoli Ruemu Birhiray Marianna Bitiņa Ron Blachy Kimberly Blackwell Rita A. Blanchard Paulette Blanchet Ion Boiangiu B. Bower Christine Brezden‐Masley Adam Brufsky Leanne S. Budde Priscilla B. Caguioa Lourdes Calvo Mario Campone Robert R. Carroll Hugo R. Castro Valorie F. Chan Veena Charu Saverio Cinieri Michael Clemens Emilio Alba Eduardo Côrtes Bruno Coudert Eduardo Cronemberger Daniel de Iracema Gomes Cubero Shaker R. Dakhil Brooke Daniel Neville Davidson Maria de Fátima Dias Gauí Susana De La Cruz María del Pilar G. Delgado John Ellerton César Estuardo Louis Fehrenbacher Jean‐Marc Ferrero Patrick J. Flynn Małgorzata Foszczyńska‐Kłoda Sandra Franco Hirofumi Fujii Chris Gallagher Teresa Gamucci N Giacomi Miguel Gil Gil Antonio González‐Martín Vera Gorbunova E. Gotovkin Nathan Green Elza Grincuka Eva‐Maria Grischke Vincent Hansen Jeffrey B. Hargis Maik Hauschild Roberto Hegg Carolyn B. Hendricks Róbert Hermann Paulo M. Hoff Jun Horiguchi Javier Hornedo Muguiro Stefano Iacobelli Kenichi Inoue Gustavo Ismael Yoshinori Itoh Dr Hiroji Iwata D Jendiroba Rosa Jochim

10.1016/s1470-2045(19)30863-0 article EN The Lancet Oncology 2020-03-12
Ellen L. Goode Matthew S. Block Kimberly R. Kalli Robert A. Vierkant Wenqian Chen and 94 more Zachary C. Fogarty Aleksandra Gentry‐Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L. Bouligny Allan Jensen Ana Osório Andreas D. Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M. Magliocco Arndt Hartmann Audrey Jung Bo Gao Brenda Y. Hernandez Brooke L. Fridley Bryan M. McCauley Catherine J. Kennedy Chen Wang Chloe Karpinskyj Christiani Bisinoto de Sousa Daniel Guimarães Tiezzi David L. Wachter Esther Herpel Florin‐Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donás Jill Nation Jillian A. Hung José Palacios Joseph H. Rothstein Joseph L. Kelley Jurandyr Moreira de Andrade Luis A. Díaz‐Robles Maria P. Intermaggio Martin Widschwendter Matthias W. Beckmann Matthias Ruebner Mercedes Jimenez‐Liñan Naveena Singh Oleg Oszurek Paul R. Harnett Peter Rambau Hans‐Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P. Edwards Roberta B. Ness Sandra Oršulić Sara Y. Brucker Sharon E. Johnatty Teri A. Longacre Ursula Eilber Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S. Whittemore Anna deFazio Annette Staebler Beth Y. Karlan C. Blake Gilks David D.L. Bowtell Estrid Høgdall Francisco José Cândido dos Reis Helen Steed Ian Campbell Jacek Gronwald Javier Benı́tez Jennifer M. Koziak Jenny Chang‐Claude Kirsten B. Moysich Linda E. Kelemen Linda S. Cook Marc T. Goodman María J. García Peter A. Fasching Stefan Kommoss Suha Deen Susanne K. Kjær Usha Menon James D. Brenton Paul D.P. Pharoah Georgia Chenevix‐Trench David G. Huntsman Stacey J. Winham Martin Köbel Susan J. Ramus

Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns TILs by histotype and relation to other clinical factors.

10.1001/jamaoncol.2017.3290 article EN JAMA Oncology 2017-10-19

The aggressiveness of invasive ductal carcinoma (IDC) the breast is associated with increased IL17 levels. Studying role in tumor pathogenesis, we found that metastatic primary tumor-infiltrating T lymphocytes produced elevated levels IL17, whereas neutralization inhibited growth and prevented migration neutrophils cells to secondary disease sites. Tumorigenic promote progression, producing CXCL1, MMP9, VEGF, TNFα, their depletion suppressed growth. IL17A also induced IL6 CCL20 production...

10.1158/0008-5472.can-15-0054 article EN Cancer Research 2015-07-25

Breast cancer is a leading cause of neoplasia‐associated death in women worldwide. Regulatory T (Treg) and Th17 cells are enriched within some tumors, but the role these play invasive ductal carcinoma (IDC) breast unknown. We show that CD25 + CD4 from PBMCs tumor express high levels Foxp3, GITR, CTLA‐4, CD103, indicating tumor‐infiltrating Treg functional possibly recruited by CCL22. Additionally, we observed upregulation Th17‐related molecules (IL‐17A, RORC, CCR6) IL‐17A produced CD8...

10.1002/eji.201242951 article EN European Journal of Immunology 2013-03-26
Peter Rambau Robert A. Vierkant Maria P. Intermaggio Linda E. Kelemen Marc T. Goodman and 91 more Esther Herpel Paul D.P. Pharoah Stefan Kommoss Mercedes Jimenez‐Liñan Beth Y. Karlan Aleksandra Gentry‐Maharaj Usha Menon Susanna Hernando Polo Francisco José Cândido dos Reis Jennifer A. Doherty Simon A. Gayther Raghwa Sharma Melissa C. Larson Paul R. Harnett Emma Hatfield Jurandyr Moreira de Andrade Gregg Nelson Helen Steed Joellen M. Schildkraut Micheal E Carney Estrid Høgdall Alice S. Whittemore Martin Widschwendter Catherine J. Kennedy Frances Wang Qin Wang Chen Wang Sebastian M. Armasu Frances Daley Penny Coulson Michael E. Jones Michael S. Anglesio Christine Chow Anna de Fazio Montserrat García‐Closas Sara Y. Brucker Cezary Cybulski Holly R. Harris Andreas D. Hartkopf Tomasz Huzarski Allan Jensen Jan Lubiński Oleg Oszurek Javier Benı́tez Fady Mina Annette Staebler Florin‐Andrei Taran J Pasternak Aline Talhouk Mary Anne Rossing Joy Hendley Robert P. Edwards Sián Fereday Francesmary Modugno Roberta B. Ness Weiva Sieh Mona El‐Bahrawy Stacey J. Winham Jenny Lester Susanne K. Kjær Jacek Gronwald Hans‐Peter Sinn Peter A. Fasching Jenny Chang‐Claude Kirsten B. Moysich David D.L. Bowtell Brenda Y. Hernandez Hugh Luk Sabine Behrens Mitul Shah Audrey Jung Prafull Ghatage Jennifer Alsop Kathryn Alsop Jesús García-Donás Pamela J. Thompson Anthony J. Swerdlow Chloe Karpinskyj Alicia Cazorla María J. García Susha Deen Lynne R. Wilkens J.M. Palacios Andrew Berchuck Jennifer M. Koziak James D. Brenton Linda S. Cook Ellen L. Goode David G. Huntsman Susan J. Ramus Martin Köbel

Abstract We aimed to validate the prognostic association of p16 expression in ovarian high‐grade serous carcinomas (HGSC) and explore it other carcinoma histotypes. protein was assessed by clinical‐grade immunohistochemistry 6525 including 4334 HGSC using tissue microarrays from 24 studies participating Ovarian Tumor Tissue Analysis consortium. patterns were interpreted as abnormal (either overexpression referred block or absence) normal (heterogeneous). CDKN2A (which encodes p16) mRNA also...

10.1002/cjp2.109 article EN cc-by The Journal of Pathology Clinical Research 2018-07-31
Filipe Correia Martins Dominique‐Laurent Couturier Anna Paterson Anthony N. Karnezis Christine Chow and 92 more Tayyebeh M. Nazeran Adekunle Odunsi Aleksandra Gentry‐Maharaj Aleksandra Vrvilo Alexander Hein Aline Talhouk Ana Osório Andreas D. Hartkopf Angela Brooks‐Wilson Anna deFazio Anna Fischer Arndt Hartmann Brenda Y. Hernandez Bryan M. McCauley Chloe Karpinskyj Christiani Bisinoto de Sousa Claus Høgdall Daniel Guimarães Tiezzi Esther Herpel Florin‐Andrei Taran Francesmary Modugno Gary L. Keeney Gregg Nelson Helen Steed Honglin Song Hugh Luk Javier Benı́tez Jennifer Alsop Jennifer M. Koziak Jenny Lester Joseph H. Rothstein Jurandyr Moreira de Andrade Lene Lundvall Luis Paz‐Ares Luis A. Díaz‐Robles Lynne R. Wilkens María J. García Maria P. Intermaggio Marie-Lyne Alcaraz Mary Anne Brett Matthias W. Beckmann Mercedes Jimenez‐Liñan Michael S. Anglesio Michael E. Carney Michael Schneider Nadia Traficante Nadja Pejovic Naveena Singh Nhu D. Le Hans‐Peter Sinn Prafull Ghatage Ramona Erber Robert P. Edwards Robert A. Vierkant Roberta B. Ness Samuel Leung Sandra Oršulić Sara Y. Brucker Scott H. Kaufmann Sián Fereday Simon A. Gayther Stacey J. Winham Stefan Kommoss Tanja Pejović Teri A. Longacre Valerie McGuire Valerie Rhenius Weiva Sieh Yurii B. Shvetsov Alice S. Whittemore Annette Staebler Beth Y. Karlan Cristina Rodríguez‐Antona David D.L. Bowtell Ellen L. Goode Estrid Høgdall Francisco José Cândido dos Reis Jacek Gronwald Jenny Chang‐Claude Kirsten B. Moysich Linda E. Kelemen Linda S. Cook Marc T. Goodman Peter A. Fasching Robin Crawford Suha Deen Usha Menon David G. Huntsman Martin Köbel Susan J. Ramus Paul D.P. Pharoah James D. Brenton

PTEN loss is a putative driver in histotypes of ovarian cancer (high-grade serous (HGSOC), endometrioid (ENOC), clear cell (CCOC), mucinous (MOC), low-grade (LGSOC)). We aimed to characterise expression as biomarker epithelial large population-based study.

10.1038/s41416-020-0900-0 article EN cc-by British Journal of Cancer 2020-06-17

Neoadjuvant chemotherapy has been considered the standard care in locally advanced breast cancer. However, about 20% of patients do not benefit from this clinical treatment and, predictive factors response were defined yet. This study was designed to evaluate importance biological markers predict and prognosis stage II III cancer treated with taxane anthracycline combination as neoadjuvant setting. Sixty received preoperative docetaxel (75 mg/m2) epirubicin (50 i.v. infusion D1 every 3 weeks...

10.1186/1471-2407-7-36 article EN cc-by BMC Cancer 2007-02-26

Invasive lobular carcinoma (ILC) and neoplasia (LN) are two distinct conditions that still pose challenges regarding to their classification, diagnosis management. Although they share similar cellular characteristics, such as discohesive neoplastic cells absence of e-cadherin staining, represent completely different conditions. LN encompasses atypical hyperplasia (ALH) in situ (LCIS), which currently considered risk factors non-obligatory precursors breast neoplasia. These lesions diagnosed...

10.1007/s13244-014-0324-6 article EN cc-by Insights into Imaging 2014-03-16

The diagnosis and treatment of breast cancer may negatively affect the quality life (QOL) women.The aim this study is to assess QOL in women with who were treated or without chemotherapy identify factors associated improved worsening these women.This cross-sectional enrolled 112 (CTX group, 85 [75.9%] women) (non-CTX 27 [24.1%] for cancer. Short-Form Health Survey (SF-36) assessed Hospital Anxiety Depression scale anxiety depression.The overall mean SF-36 score was below 50 all domains....

10.1097/ncc.0000000000000370 article EN Cancer Nursing 2016-04-19

Breast cancer is the most common in women worldwide and metastatic dissemination principal factor related to death by this disease. stem cells (bCSC) are thought be responsible for metastasis chemoresistance. In study, based on whole transcriptome analysis from putative bCSC reverse engineering of transcription control networks, we identified two networks associated with phenotype. One controlled SNAI2, TWIST1, BNC2, PRRX1 TBX5 drives a mesenchymal or CSC-like The second network SCML4,...

10.1038/s41598-017-02761-6 article EN cc-by Scientific Reports 2017-05-31

O uso de plantas medicinais é uma prática ancestral que vem ganhando espaço na saúde pública brasileira nos últimos anos, especialmente com a implementação da Política Nacional Práticas Integrativas e Complementares (PNPIC) no Sistema Único Saúde (SUS). Esta revisão narrativa tem como objetivo analisar literatura recente sobre o atenção básica, destacando seus benefícios, desafios perspectivas. Foram consultadas bases SciELO, BVS PubMed, priorizando estudos publicados entre 2015 2024. Os...

10.55905/revconv.18n.4-280 article PT Contribuciones a las Ciencias Sociales 2025-04-24

The role of immune system in the pathogenesis and progression breast cancer is a subject controversy, this stimulated us to investigate association immunophenotype tumor-infiltrating lymphocytes early with spread tumor cells axillary lymph nodes.Tumor samples from 23 patients Department Gynecology Obstetrics Ribeirão Preto Medical School (USP) were obtained at time biopsy submitted an enzyme-digestion procedure for extraction lymphocytes. extracted analyzed by dual-color flow cytometry...

10.1590/s1807-59322006000300004 article EN cc-by-nc Clinics 2006-01-01

Axillary masses are uncommon alterations when detected as an isolated finding. We evaluated 31 patients with axillary masses. Patients of the breasts or upper limbs Ipsilateral chest lesions were excluded from study. Nine had occult breast cancer, 5 them in contralateral breast. Seven metastatic lymph nodes non-ductal origin, and 1 carcinoma apocrine cells metastasis to axilla. Four benign lymphadenopathy which disappeared spontaneously, 4 others ruptured infundibular follicular cyst,...

10.1177/030089169608200617 article EN Tumori Journal 1996-11-01

Oral health can affect a patient's general and quality of life. Given the increase in breast cancer survival rates, investigations factors influencing life survivors have gained importance. Therefore, objective our study was to characterize oral postmenopausal survivors.We conducted matched case-control study. Forty-eight women who survived (age 62.1±9.1 years) 48 healthy controls 61.8±8.6 were included. For each case control, complete evaluation chart completed.The prevalence chronic...

10.6061/clinics/2014(10)10 article EN cc-by-nc Clinics 2014-10-01

Recently it has been demonstrated that constitutively activated signal transducer and activator of transcription 1 (STAT1) gene expression may act as a biomarker ovarian cancer chemotherapy response. In this study, our objective was to validate the use STAT1 immunohistochemistry prognostic for disease outcome using cohort derived from Latin America.We evaluated Brazilian high-grade serous cancer, comprising 65 patients with data covering more than 5 years determine predictive value levels....

10.1097/igc.0000000000001193 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2018-01-05

Breast cancer incidence has been substantially increasing in developing countries the last decades.[1] In Brazil, total number of new diagnosed cases reaches 60,000 a year, resulting an rate 60/100,000 women per year.[2] Despite high incidence, breast is described as relatively good prognosis cancer. The worldwide incidence/mortality 3.3.[3] However, this ratio varies within different populations with evident decrease when comparing to developed ones. impact scenario may be attributed late...

10.1055/s-0039-3399550 article EN cc-by Revista Brasileira Ginecologia e Obstetrícia 2019-11-01

Breast cancer screening is not recommended for young women (< 40 years old); therefore, those diagnosed are more likely to have advanced and metastatic disease, reducing treatment outcomes. This study aimed investigate breast epidemiology among in Brazil.Data from three publicly available databases a cohort university hospital Brazil were analyzed retrospective study. Descriptive statistics was performed on disease prevalence stage distribution across age groups. Incidence estimated using...

10.1200/go.20.00440 article EN cc-by-nc-nd JCO Global Oncology 2021-01-12

Aims and background There is an enhanced immune response in patients with breast cancer after the use of chemotherapy. The objective this study was therefore to investigate alterations number peripheral lymphocytes neoadjuvant chemotherapy (NC) relationship prognosis. Methods Thirty women were analyzed. Their UICC staging IIb (only T3N0 included) III (N3 not included). Sample analysis performed using flow cytometry before first cycle 18 21 days last NC. lymphocyte subsets studied were: T...

10.1177/030089160008600507 article EN Tumori Journal 2000-09-01
Matthew S. Block Robert A. Vierkant Peter Rambau Stacey J. Winham Philipp Wagner and 95 more Nadia Traficante Aleksandra Tołoczko Daniel Guimarães Tiezzi Florin‐Andrei Taran Hans‐Peter Sinn Weiva Sieh Raghwa Sharma Joseph H. Rothstein Teresa Ramón y Cajal Luis Paz‐Ares Oleg Oszurek Sandra Oršulić Roberta B. Ness Gregg Nelson Francesmary Modugno Janusz Menkiszak Valerie McGuire Bryan M. McCauley Marie Mack Jan Lubiński Teri A. Longacre Zheng Li Jenny Lester Catherine J. Kennedy Kimberly R. Kalli Audrey Jung Sharon E. Johnatty Mercedes Jimenez‐Liñan Allan Jensen Maria P. Intermaggio Jillian A. Hung Esther Herpel Brenda Y. Hernandez Andreas D. Hartkopf Paul R. Harnett Prafull Ghatage Jose Maria Garcia-Bueno Bo Gao Sián Fereday Ursula Eilber Robert P. Edwards Christiani Bisinoto de Sousa Jurandyr Moreira de Andrade Anita Chudecka-Głaz Georgia Chenevix‐Trench Alicia Cazorla Sara Y. Brucker Jennifer Alsop Alice S. Whittemore Helen Steed Annette Staebler Kirsten B. Moysich Usha Menon Jennifer M. Koziak Stefan Kommoss Susanne K. Kjær Linda E. Kelemen Beth Y. Karlan David G. Huntsman Estrid Høgdall Jacek Gronwald Marc T. Goodman C. Blake Gilks María J. García Peter A. Fasching Anna de Fazio Suha Deen Jenny Chang‐Claude Francisco José Cândido dos Reis Ian Campbell James D. Brenton David D.L. Bowtell Javier Benı́tez Paul D.P. Pharoah Martin Köbel Susan J. Ramus Ellen L. Goode David D.L. Bowtell Georgia Chenevix‐Trench A. Green Penelope M. Webb Anna deFazio Dorota M. Gertig Nadia Traficante Sián Fereday S. Moore Jillian A. Hung K.R. Harrap T. Sadkowsky Nirmala Pandeya M. Malt A. Mellon R. Paul Robertson T. Vanden Bergh Marsha Jones

ObjectiveTo evaluate myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 (TLR4) expression in relation to clinical features of epithelial ovarian cancer, histologic subtypes, overall survival.Patients MethodsWe conducted centralized immunohistochemical staining, semi-quantitative scoring, survival analysis 5263 patients participating the Ovarian Tumor Tissue Analysis consortium. Patients were diagnosed between January 1, 1978, December 31, 2014, including 2865...

10.1016/j.mayocp.2017.10.023 article EN cc-by-nc-nd Mayo Clinic Proceedings 2018-03-01
Coming Soon ...